Skytrofa is a long-acting form of somatropin. Somatropin is also called human growth hormone. Skytrofa is also considered a pegylated somatropin product. Pegylated means the medication is attached to ...

Growth hormone helps children grow in height and supports healthy metabolism. When a child does not have enough of this hormone, their growth may be slow. This is sometimes called growth failure.

A comparison of morning and evening growth hormone injection schedules in children with growth disorders showed no significant differences in sleep-wake patterns, sleep duration, or daytime activity, ...

New, longer-acting treatment offers option to reduce the frequency of injections for children with growth hormone deficiency from daily to once-weekly Growth hormone deficiency (GHD) is a rare disease ...

(Reuters) -The U.S. Food and Drug Administration has approved Pfizer Inc and partner OPKO Health Inc's treatment for growth hormone deficiency in children, the companies said on Wednesday. The ...

The US FDA has approved Novo Nordisk’s once-weekly growth hormone somapacitan-beco (Sogroya) for three new pediatric indications. The approval was based on findings from the first year of REAL8, a ...

In 1957, Maurice Raben successfully isolated and purified the growth hormone (GH) from the pituitary gland, opening up a potential avenue of GH therapies. Children who were born with a deficiency of ...

NEW YORK (Reuters Health) - Daily injections of growth hormone may help reduce pain and improve the quality of life in some patients with fibromyalgia, new findings of a small study suggest.

The FDA approved long-acting injectable somatrogon (Ngenla) for pediatric human growth hormone deficiency, developers Pfizer and OPKO Health announced this week. Somatrogon is indicated for children ...

June 28 (Reuters) - The U.S. Food and Drug Administration has approved Pfizer Inc (PFE.N), opens new tab and partner OPKO Health Inc's (OPK.O), opens new tab treatment for growth hormone deficiency in ...